This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1999 Jul 7;91(13):1167-8.

doi: 10.1093/jnci/91.13.1167.

Delayed adjuvant tamoxifen in postmenopausal women with axillary node-negative breast cancer: mortality over 10 years

R R Love, M R Olsen, T C Havighurst

PMID: 10393732
DOI: 10.1093/jnci/91.13.1167

Delayed adjuvant tamoxifen in postmenopausal women with axillary node-negative breast cancer: mortality over 10 years

R R Love et al. J Natl Cancer Inst. 1999.

. 1999 Jul 7;91(13):1167-8.

doi: 10.1093/jnci/91.13.1167.

Authors

R R Love, M R Olsen, T C Havighurst

PMID: 10393732
DOI: 10.1093/jnci/91.13.1167

No abstract available

PubMed Disclaimer

Similar articles

Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer. Swedish Breast Cancer Cooperative Group.
[No authors listed] [No authors listed] J Natl Cancer Inst. 1996 Nov 6;88(21):1543-9. doi: 10.1093/jnci/88.21.1543. J Natl Cancer Inst. 1996. PMID: 8901852 Clinical Trial.
Postchemotherapy adjuvant tamoxifen therapy beyond five years in patients with lymph node-positive breast cancer. Eastern Cooperative Oncology Group.
Tormey DC, Gray R, Falkson HC. Tormey DC, et al. J Natl Cancer Inst. 1996 Dec 18;88(24):1828-33. doi: 10.1093/jnci/88.24.1828. J Natl Cancer Inst. 1996. PMID: 8961972 Clinical Trial.
Five years of tamoxifen--or more?
Peto R. Peto R. J Natl Cancer Inst. 1996 Dec 18;88(24):1791-3. doi: 10.1093/jnci/88.24.1791. J Natl Cancer Inst. 1996. PMID: 8961965 No abstract available.
The duration of adjuvant tamoxifen therapy.
Bilimoria MM, Jordan VC. Bilimoria MM, et al. Cancer Treat Res. 1998;94:181-93. doi: 10.1007/978-1-4615-6189-7_10. Cancer Treat Res. 1998. PMID: 9587688 Review. No abstract available.
Reducing the risk for breast cancer recurrence after completion of tamoxifen treatment in postmenopausal women.
Jahanzeb M. Jahanzeb M. Clin Ther. 2007 Aug;29(8):1535-47. doi: 10.1016/j.clinthera.2007.08.013. Clin Ther. 2007. PMID: 17919537 Review.

See all similar articles

Cited by

Late tamoxifen in patients previously operated for breast cancer without postoperative tamoxifen: 5-year results of a single institution randomised study.
Veronesi A, Miolo G, Magri MD, Crivellari D, Scalone S, Bidoli E, Lombardi D. Veronesi A, et al. BMC Cancer. 2010 May 14;10:205. doi: 10.1186/1471-2407-10-205. BMC Cancer. 2010. PMID: 20470379 Free PMC article. Clinical Trial.
Impact of Fertility Concerns on Tamoxifen Initiation and Persistence.
Llarena NC, Estevez SL, Tucker SL, Jeruss JS. Llarena NC, et al. J Natl Cancer Inst. 2015 Aug 25;107(10):djv202. doi: 10.1093/jnci/djv202. Print 2015 Oct. J Natl Cancer Inst. 2015. PMID: 26307641 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information